Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
6,15 HKD | -1,91% | -5,24% | -15,29% |
Vakgebied
- geneesmiddelen (78,7%): innovatieve geneesmiddelen (62,5% van de verkoop) en gewone generieke geneesmiddelen (37,5%);
- vitamine C (10,1%)
- antibiotica (6,2%);
- overige (5%): inclusief watervrije en ruwe cafeïne.
De netto-omzet is geografisch als volgt verdeeld: China (82,8%), Azië (7,2%), Europa (4,6%), Noord- en Zuid-Amerika (4,4%) en overige (1%).
Aantal werknemers: 23 500
Verkoop per activiteit
HKD in miljoen | 2021 | Gewicht | 2022 | Gewicht | Delta |
---|---|---|---|---|---|
Finished Drugs
79,3
%
| 22 681 | 81,4 % | 24 520 | 79,3 % | +8,11% |
Vitamin C
8,2
%
| 2 149 | 7,7 % | 2 529 | 8,2 % | +17,68% |
Functional Food and Others
6,4
%
| 1 366 | 4,9 % | 1 966 | 6,4 % | +43,89% |
Antibiotics and Others
6,2
%
| 1 670 | 6,0 % | 1 922 | 6,2 % | +15,07% |
Verkoop per regio
HKD in miljoen | 2021 | Gewicht | 2022 | Gewicht | Delta |
---|---|---|---|---|---|
China
84,5
%
| 24 289 | 87,2 % | 26 139 | 84,5 % | +7,62% |
Other Asian Regions
5,6
%
| 1 475 | 5,3 % | 1 736 | 5,6 % | +17,71% |
Americas
4,9
%
| 1 159 | 4,2 % | 1 510 | 4,9 % | +30,23% |
Europe
4,1
%
| 700 | 2,5 % | 1 268 | 4,1 % | +81,08% |
Others
0,9
%
| 244 | 0,9 % | 284 | 0,9 % | +16,37% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Cuilong Zhang
CEO | Chief Executive Officer | 55 | 01-01-96 |
Dong Chen Cai
CHM | Chairman | 70 | 01-01-98 |
Hao Jiang
BRD | Director/Board Member | 41 | 01-08-20 |
Zhen Guo Wang
BRD | Director/Board Member | 54 | 20-01-12 |
Huai Yu Wang
BRD | Director/Board Member | 61 | 01-01-10 |
Wei Dong Pan
BRD | Director/Board Member | 55 | 01-01-06 |
Jin Xu Wang
PRN | Corporate Officer/Principal | 53 | 10-06-13 |
Tai On Lo
SEC | Corporate Secretary | 69 | 01-01-21 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Dong Chen Cai
CHM | Chairman | 70 | 01-01-98 |
Cheuk Kin Law
BRD | Director/Board Member | 62 | 08-03-21 |
Kin Man Chak
BRD | Director/Board Member | 58 | 01-01-05 |
Zhen Guo Wang
BRD | Director/Board Member | 54 | 20-01-12 |
Chun Kwok Au
BRD | Director/Board Member | 51 | 27-01-21 |
Jin Xu Wang
PRN | Corporate Officer/Principal | 53 | 10-06-13 |
Chun Lei Li
BRD | Director/Board Member | - | 12-12-17 |
Cuilong Zhang
CEO | Chief Executive Officer | 55 | 01-01-96 |
Qingxi Wang
BRD | Director/Board Member | 58 | 20-08-18 |
Hao Jiang
BRD | Director/Board Member | 41 | 01-08-20 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 11 903 219 732 | 8 371 200 069 ( 70,33 %) | 0 | 70,33 % |
Participaties
Naam | Aandelen | % | Totale waarde |
---|---|---|---|
131 267 092 | 69.84% | 624 651 522 $ | |
51 241 785 | 46.32% | 56 289 613 $ |
Bedrijfsgegevens
CSPC Pharmaceutical Group Ltd.
No. 226 Huanghe Street
050035, Shijiazhuang
+86 31 1870 37015
http://www.cspc.com.hkSector
Verkoop per activiteit
Verkoop per regio
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-15,29% | 9,31 mld. | |
+33,46% | 701 mld. | |
+26,24% | 570 mld. | |
+0,93% | 381 mld. | |
+21,03% | 334 mld. | |
+17,51% | 322 mld. | |
+2,95% | 212 mld. | |
+0,74% | 209 mld. | |
-6,05% | 205 mld. | |
-3,61% | 157 mld. |
- Beurs
- Aandelen
- Aandeel CSPC Pharmaceutical Group Ltd. - Hong Kong S.E.
- Onderneming CSPC Pharmaceutical Group Ltd.